NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.90 +0.05 (+1.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Return on Assets [ROA] (2018 - 2026)

Updated

NRX Pharmaceuticals (NRXP) reported Return on Assets [ROA] of -91.27% for Q2 2026, up 118.17 percentage points from -209.45% a year earlier and up 53.63 percentage points from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For FY2025, NRX Pharmaceuticals posted Return on Assets [ROA] of -203.32%, up 137.51 percentage points from FY2024.

  • Return on Assets [ROA] has a five-year change of +92.51 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -340.84% in FY2024 (-175.05 pp), -165.78% in FY2023 (-29.98 pp), -135.81% in FY2022 (+385.99 pp) and -521.80% in FY2021 (-225.96 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Assets [ROA] since Q3 2020.
  • Year over year, Return on Assets [ROA] has now increased in each of the last six quarters, with an average year-over-year change of +104.94 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q4 2021 (a gain of 935.71 percentage points); the low point was Q2 2024 (a drop of 369.09 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -144.91% (Q1 2026), -120.81% (Q4 2025) and -141.38% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 NRX Pharmaceuticals 125.16 Mn 76.75 Mn 426,000.00 -91.27%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -91.27%
Mar 31, 2026 -144.91%
Dec 31, 2025 -120.81%
Sep 30, 2025 -141.38%
Jun 30, 2025 -209.45%
Mar 31, 2025 -290.54%
Dec 31, 2024 -460.69%
Sep 30, 2024 -425.09%
Jun 30, 2024 -516.68%
Mar 31, 2024 -439.25%
Dec 31, 2023 -215.69%
Sep 30, 2023 -166.31%
Jun 30, 2023 -147.59%
Mar 31, 2023 -135.41%
Dec 31, 2022 -174.13%
Sep 30, 2022 -226.13%
Jun 30, 2022 -243.95%
Mar 31, 2022 -218.22%
Dec 31, 2021 -175.60%
Sep 30, 2021 -260.77%
API Access

NRX Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NRXP&period=max&api_key=YOUR_API_KEY